Advertisement

Topics

Startup Specializing in Genetic Medicines Raises $83.5M in Series B Financing

14:00 EDT 3 Aug 2017 | Drug Discovery Development

The proceeds are expected to be used to advance lead development candidate that is currently in preclinical IND-enabling studies for inborn error of metabolism disease.
Contributed Author: 
Homology
Topics: 

Original Article: Startup Specializing in Genetic Medicines Raises $83.5M in Series B Financing

NEXT ARTICLE

More From BioPortfolio on "Startup Specializing in Genetic Medicines Raises $83.5M in Series B Financing"

Quick Search
Advertisement